There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Contractility of the nonmuscle and smooth muscle cells that comprise biological tubing
is regulated by the Rho-ROCK (Rho-associated protein kinase) and calcium signaling
pathways. Although many molecular details about these signaling pathways are known,
less is known about how they are coordinated spatiotemporally in biological tubes.
The spermatheca of the Caenorhabditis elegans reproductive system enables study of
the signaling pathways regulating actomyosin contractility in live adult animals.
The RhoGAP (GTPase-activating protein toward Rho family small GTPases) SPV-1 was
previously identified as a negative regulator of RHO-1/Rho and spermathecal contractility.
Here, we uncover a role for SPV-1 as a key regulator of calcium signaling. spv-1 mutants
expressing the calcium indicator GCaMP in the spermatheca exhibit premature calcium
release, elevated calcium levels, and disrupted spatial regulation of calcium signaling
during spermathecal contraction. Although RHO-1 is required for spermathecal contractility,
RHO-1 does not play a significant role in regulating calcium. In contrast, activation
of CDC-42 recapitulates many aspects of spv-1 mutant calcium signaling. Depletion
of cdc-42 by RNA interference does not suppress the premature or elevated calcium
signal seen in spv-1 mutants, suggesting other targets remain to be identified. Our
results suggest that SPV-1 works through both the Rho-ROCK and calcium signaling pathways
to coordinate cellular contractility.
Ca2+ sensitivity of smooth muscle and nonmuscle myosin II reflects the ratio of activities of myosin light-chain kinase (MLCK) to myosin light-chain phosphatase (MLCP) and is a major, regulated determinant of numerous cellular processes. We conclude that the majority of phenotypes attributed to the monomeric G protein RhoA and mediated by its effector, Rho-kinase (ROK), reflect Ca2+ sensitization: inhibition of myosin II dephosphorylation in the presence of basal (Ca2+ dependent or independent) or increased MLCK activity. We outline the pathway from receptors through trimeric G proteins (Galphaq, Galpha12, Galpha13) to activation, by guanine nucleotide exchange factors (GEFs), from GDP. RhoA. GDI to GTP. RhoA and hence to ROK through a mechanism involving association of GEF, RhoA, and ROK in multimolecular complexes at the lipid cell membrane. Specific domains of GEFs interact with trimeric G proteins, and some GEFs are activated by Tyr kinases whose inhibition can inhibit Rho signaling. Inhibition of MLCP, directly by ROK or by phosphorylation of the phosphatase inhibitor CPI-17, increases phosphorylation of the myosin II regulatory light chain and thus the activity of smooth muscle and nonmuscle actomyosin ATPase and motility. We summarize relevant effects of p21-activated kinase, LIM-kinase, and focal adhesion kinase. Mechanisms of Ca2+ desensitization are outlined with emphasis on the antagonism between cGMP-activated kinase and the RhoA/ROK pathway. We suggest that the RhoA/ROK pathway is constitutively active in a number of organs under physiological conditions; its aberrations play major roles in several disease states, particularly impacting on Ca2+ sensitization of smooth muscle in hypertension and possibly asthma and on cancer neoangiogenesis and cancer progression. It is a potentially important therapeutic target and a subject for translational research.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.